ARTEBONE Bone Void Filler in Arthrodesis Procedure of the Ankle

NCT02480868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2017-12-20

No results posted yet for this study

Summary

The purpose of this investigation is to assess safety and performance of ARTEBONE Bone Void Filler in the single arthrodesis procedure.

Conditions

Interventions

DEVICE

ARTEBONE

4,3 g Bone Void Filler

Sponsors & Collaborators

  • BBS-Bioactive Bone Substitutes Oy

    lead INDUSTRY

Principal Investigators

  • Juhana Leppilahti, Professor · Oulu University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-12-14
Completion
2017-12-14

Countries

  • Finland
  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02480868 on ClinicalTrials.gov